{"slideshow_credits": null, "snippet": "AbbVie said that it had increased its bid to acquire the Irish drug maker that had rejected its previous takeover offer. The new bid is about $51.6 billion.", "abstract": "AbbVie said that it had increased its bid to acquire the Irish drug maker that had rejected its previous takeover offer. The new bid is about $51.6 billion.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}, {"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 2, "organization": ""}], "original": "By DAVID GELLES and CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/07/08/abbvie-raises-bid-for-irish-drug-maker-shire/", "lead_paragraph": null, "headline": {"main": "U.S. Drug Maker AbbVie Increases Bid for Shire, as Cost of Moving Abroad Rises", "print_headline": "U.S. Drug Maker AbbVie Increases Bid for Shire, as Cost of Moving Abroad Rises", "kicker": "DealBook"}, "_id": "53bbe85a38f0d847f10f5e31", "word_count": "838", "multimedia": [{"height": 126, "url": "images/2014/07/09/business/dbpix-adderall/dbpix-adderall-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/07/09/business/dbpix-adderall/dbpix-adderall-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/07/09/business/dbpix-adderall/dbpix-adderall-articleLarge.jpg", "legacy": {"xlarge": "images/2014/07/09/business/dbpix-adderall/dbpix-adderall-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/07/09/business/dbpix-adderall/dbpix-adderall-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/07/09/business/dbpix-adderall/dbpix-adderall-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-07-08T08:46:34Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Shire PLC", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "AbbVie Inc", "name": "organizations", "is_major": "Y", "rank": "1"}, {"name": "persons", "value": "Gonzalez, Richard", "rank": "1"}, {"name": "persons", "value": "Obama, Barack", "rank": "2"}, {"name": "glocations", "value": "United States", "rank": "4"}, {"name": "glocations", "value": "Ireland", "rank": "3"}, {"name": "glocations", "value": "Great Britain", "rank": "2"}, {"name": "glocations", "value": "Chicago (Ill)", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}, {"name": "subject", "value": "Federal Taxes (US)", "rank": "2"}, {"name": "subject", "value": "Taxation", "rank": "5"}, {"name": "subject", "value": "Stocks and Bonds", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}